Primary Research · 2004
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis
Ziegler D, Nowak H, Kempler P, et al. · Diabetic Medicine, 2004
Key finding
Meta-analysis of 4 RCTs (n=1,258) found 3 weeks of IV ALA 600mg/day significantly improved neuropathic symptoms in diabetic patients — the strongest evidence tier supporting ALA for diabetic neuropathy.
About the supplement
Alpha-Lipoic Acid (ALA)
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/14984445/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.